
European Journal of Medicinal Chemistry p. 55 - 60 (1994)
Update date:2022-08-04
Topics:
Pinna, G.A.
Cignarella, G.
Scolastico, S.
Porceddu, M.L.
1-(3-hydroxy-4-methoxybenzyl)-2-alkyl-6,7-methylenedioxytetrahydroisoquinolines (3a-c), derived from the D1 selective antagonist S-bulbocapnine by cleavage of the bond between the 2 aromatic moieties, have been synthesized and their in vitro affinity towards D1 and D2 receptors evaluated.Of the compounds tested, the 2-methyl derivative 3a while showing poor affinity towards D1 receptors was able to inhibit the D2 radioligand 3H-raclopride binding by 60percent at 10-5 M.Conformational analysis allows reasonable explanations of the loss of D1-affinity of 3a with respect to the model. substituted 1-(3-hydroxy-4-methoxybenzyl)-6,7-methylenedioxytetrahydroisoquinoline / D1 and D2 receptor binding / bulbocapnine conformational analysis
View MoreSuzhou Jingye Medicine & Chemical Co., Ltd
Contact:+86-512-66658588
Address:No. 88, Sanlian Street, Jinfeng Road, Suzhou New District, Jiangsu Province, P. R. China
Contact:0086-357-6662688
Address:Zhaocheng town, Hongtong County, Linfen City, Shanxi Province
Yixing Zhenfen Medical Chemical Co.Ltd
Contact:86-510-87552708
Address:Fenshui ,Yixing city,Jiangsu
Contact:+86-731-84427351
Address:154 JIANXIANG SOUTH ROAD
Suzhou Tianma Specialty Chemicals Co.,Ltd
Contact:+86-512-68090577
Address:#199, Huayuan Rd, Mudu, Suzhou, Jiangsu, CHINA
Doi:10.1080/14756366.2020.1838501
(2021)Doi:10.1021/cm401512c
(2013)Doi:10.1039/c3dt51065d
(2013)Doi:10.1002/cmdc.201300078
(2013)Doi:10.1016/0040-4020(67)85101-9
(1967)Doi:10.1021/ja4052075
(2013)